NeuroSearch A/S

NEUR 
(NasdaqOMXC) 
 

News about NeuroSearch A/S

  • Local
  • International
  • Company messages

Popular news

1
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Aaron’s, Inc. (NYSE: AAN) To Contact Brower Piven Before The Lead Plaintiff Deadline
2
AARON’S SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Aaron’s, Inc. - AAN
3
K2M Introduces First-of-Its-Kind SAHARA™ AL Expandable Stabilization System
4
Novartis combination targeted therapy Tafinlar® + Mekinist® receives FDA approval for BRAF V600E mutant metastatic non-small cell lung cancer (NSCLC)
5
JUNE 19 DEADLINE: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Amyris, Inc. and Reminds Investors with Losses to Contact the Firm
6
Amundi announces the upcoming completion of the acquisition of Pioneer Investments and presents its future organisation
7
Alliance Trust PLC : Transaction in Own Shares (correction)
8
Orange successfully completes the sale of BT shares and secures financing at a negative interest rate
9
Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix® (vortioxetine) sNDA
10
Novo Nordisk receives positive 17-2 vote from FDA Advisory Committee that Victoza® provides substantial evidence of cardiovascular risk reduction in patients with type 2 diabetes

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
24 June 2017 06:18:55
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170623.1 - EUROWEB4 - 2017-06-24 07:18:55 - 2017-06-24 06:18:55 - 1000 - Website: OKAY